GSK-3 Inhibitors: Anti-Diabetic Treatment Associated with Cardiac Risk?

Miranda Nabben*, Dietbert Neumann

*Corresponding author for this work

    Research output: Contribution to journalEditorialAcademicpeer-review

    Original languageEnglish
    Pages (from-to)233-235
    JournalCardiovascular Drugs and Therapy
    Volume30
    Issue number3
    DOIs
    Publication statusPublished - Jun 2016

    Cite this